Larizza L, Schirrmacher V, Graf L, Pflüger E, Peres-Martinez M, Stöhr M
Int J Cancer. 1984 Nov 15;34(5):699-707. doi: 10.1002/ijc.2910340518.
Two lines of evidence are reported which suggest that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Firstly, ESb cells are shown to express the macrophage differentiation antigen Mac-1 which was not found on Eb cells or on any other tumor cells tested except the macrophage tumor line Pu5. Secondly, the progression from low to high metastatic capacity could be reproduced in vitro following hybridization of thioguanine-resistant Eb cells (EbTGR) with syngeneic bone-marrow-derived macrophages. Two HAT medium-selected hybrid tumor lines (Eb-F1 and Eb-F2) could be established. They were found to express cell surface markers of both parental lines: T lymphoid differentiation antigens from T-lymphoma and macrophage antigens (Mac-1, class II MHC antigens) from the normal cell fusion partner. The antigens were identified on the hybrids and subclones thereof by means of monoclonal antibodies and 3 different detection assays: cytofluorography, complement-dependent cytotoxicity and immunoprecipitation followed by gel electrophoresis. Animals inoculated s.c. with the parental line EbTGR developed local tumors but not metastases and survived for more than 40 days. In contrast, animals inoculated similarly with Eb-F1 or Eb-F2 cells quickly developed metastases in visceral organs and died as early as 10-14 days following inoculation. In many but not all respects, the in vitro-derived T-lymphoma-macrophage hybrids resembled the spontaneous in vivo-derived variant ESb. These findings, together with the presence of Mac-1 antigen on ESb cells, suggest (1) that ESb variant cells may be derived from spontaneous fusion with a host cell, most likely a macrophage and (2) that somatic cell fusion may be an important mechanism of genetic rearrangements leading to metastatic variants. The new highly metastatic tumor lines which were developed under well-defined in vitro conditions, and their subclones, may become very useful tools for studying the contribution of specific genetic traits and of membrane-related structures to various steps of the metastatic process.
有两条证据表明,T细胞淋巴瘤Eb的高转移性变体ESb源自与宿主巨噬细胞的自发融合。首先,ESb细胞被证明表达巨噬细胞分化抗原Mac-1,而在Eb细胞或除巨噬细胞瘤系Pu5外测试的任何其他肿瘤细胞上均未发现该抗原。其次,在硫代鸟嘌呤抗性Eb细胞(EbTGR)与同基因骨髓来源的巨噬细胞杂交后,体外可重现从低转移能力到高转移能力的进展。可以建立两个经HAT培养基筛选的杂交瘤系(Eb-F1和Eb-F2)。发现它们表达两个亲本品系的细胞表面标志物:来自T淋巴瘤的T淋巴细胞分化抗原和来自正常细胞融合伙伴的巨噬细胞抗原(Mac-1,II类MHC抗原)。通过单克隆抗体和3种不同检测方法在杂种及其亚克隆上鉴定抗原:细胞荧光术、补体依赖性细胞毒性和免疫沉淀后进行凝胶电泳。皮下接种亲本品系EbTGR的动物出现局部肿瘤但无转移,存活超过40天。相比之下,同样接种Eb-F1或Eb-F2细胞的动物在内脏器官中迅速出现转移,接种后最早10 - 14天死亡。在许多但并非所有方面,体外衍生的T淋巴瘤 - 巨噬细胞杂种类似于体内自发衍生的变体ESb。这些发现,连同ESb细胞上Mac-1抗原的存在,表明(1)ESb变体细胞可能源自与宿主细胞的自发融合,最有可能是巨噬细胞,以及(2)体细胞融合可能是导致转移变体的基因重排的重要机制。在明确的体外条件下开发的新的高转移性肿瘤系及其亚克隆,可能成为研究特定遗传特征和膜相关结构对转移过程各个步骤的贡献的非常有用的工具。